Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug 21;19(31):5035-50.
doi: 10.3748/wjg.v19.i31.5035.

Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management

Affiliations
Review

Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management

Erwin Biecker. World J Gastroenterol. .

Abstract

Bleeding from esophageal varices is a life threatening complication of portal hypertension. Primary prevention of bleeding in patients at risk for a first bleeding episode is therefore a major goal. Medical prophylaxis consists of non-selective beta-blockers like propranolol or carvedilol. Variceal endoscopic band ligation is equally effective but procedure related morbidity is a drawback of the method. Therapy of acute bleeding is based on three strategies: vasopressor drugs like terlipressin, antibiotics and endoscopic therapy. In refractory bleeding, self-expandable stents offer an option for bridging to definite treatments like transjugular intrahepatic portosystemic shunt (TIPS). Treatment of bleeding from gastric varices depends on vasopressor drugs and on injection of varices with cyanoacrylate. Strategies for primary or secondary prevention are based on non-selective beta-blockers but data from large clinical trials is lacking. Therapy of refractory bleeding relies on shunt-procedures like TIPS. Bleeding from ectopic varices, portal hypertensive gastropathy and gastric antral vascular ectasia-syndrome is less common. Possible medical and endoscopic treatment options are discussed.

Keywords: Band ligation; Beta-blocker; Endoscopy; Esophageal varices; Gastric antral vascular ectasia-syndrome; Gastric varices; Portal hypertension; Portal hypertensive gastropathy; Variceal bleeding.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Esophageal varices grade II in a patient with liver cirrhosis.
Figure 2
Figure 2
Variceal band ligation of esophageal varices.
Figure 3
Figure 3
Isolated gastric varices type I and portal hypertensive gastropathy in a patient with liver cirrhosis.
Figure 4
Figure 4
Acute diffuse bleeding from portal hypertensive gastropathy in a patient with decompensated liver cirrhosis.
Figure 5
Figure 5
Typical appearance of a watermelon stomach in a patient with gastric antral vascular ectasia-syndrome and compensated liver cirrhosis.
Figure 6
Figure 6
Endoscopic treatment of gastric antral vascular ectasia with argon plasma coagulation therapy.

References

    1. Calès P, Pascal JP. Natural history of esophageal varices in cirrhosis (from origin to rupture) Gastroenterol Clin Biol. 1988;12:245–254. - PubMed
    1. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–354. - PubMed
    1. Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48:229–236. - PubMed
    1. Augustin S, Altamirano J, González A, Dot J, Abu-Suboh M, Armengol JR, Azpiroz F, Esteban R, Guardia J, Genescà J. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol. 2011;106:1787–1795. - PubMed
    1. Villanueva C, Piqueras M, Aracil C, Gómez C, López-Balaguer JM, Gonzalez B, Gallego A, Torras X, Soriano G, Sáinz S, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45:560–567. - PubMed

MeSH terms

Substances